Astex Pharmaceuticals

Astex is participating in the Chariots of Fire race 2024 and running in the event in honour of Rich Hall. https://lnkd.in/g8FYvqQ Rich worked at Astex for 17 years, making important contributions to the informatics platform. Sadly, he passed away towards the end of last year. He was a good friend and colleague to many over the years. Along with being a keen runner, Rich organised several entries from Astex to this event in the past. This will be the first year Astex has entered since his passing. We'll be entering 3 teams of 6, each running to raise money for the Arthur Rank Hospice Charity, who provide end-of-life care for those with advanced serious illness. Any contribution is very welcome, and there is no amount too little. https://lnkd.in/eQkskrzp

fantastic to discuss the potential of biocatalysis for FBDD! thanks for the invite all at Astex Pharmaceuticals !

Today myself and Sebastian Cosgrove had the pleasure of visiting Astex Pharmaceuticals to give a talk on Biocatalysis. Such an enjoyable day and some fantastic discussions were had. A big thank you to Wojciech Zawodny and Jessie Stow for organising and showing us around the fantastic labs and facilities.

Last week we had a fantastic event at Alderley Park with Bruntwood SciTech hosting the 2nd Edition of Chemist in Industry SCI® Where Science Meets Business. We saw some fantastic talks from Al Dossetter from MedChemica Ltd, Rob Young from GSK and Blue Burgundy, Iacovos N. Michaelides from AstraZeneca, Emiliano Tamanini from Astex Pharmaceuticals , Damien Valette from MSD with the winner selected as Yunas Bhonoah from Syngenta. An insightful keynote presentation from Sarah Skerratt, FRSC from CHARM Therapeutics and great networking and support from Sygnature Discovery, Revvity Signals, abcr GmbH, Teledyne ISCO and Key Organics. Many thanks to all our sponsors and co-organisers for a great day!

🚀Discovery & Development Europe 2025 📅 23 - 24 June 2025, Basel, Switzerland Join 1,000 R&D leaders working in biology and chemistry in Basel at this renowned event. Gain insights to make informed pipeline decisions in early R&D, accelerating the journey from target identification to novel clinical candidates, ultimately increasing life-saving treatments for critical illnesses. Key Speakers Include: 🔹𝗧𝗮𝗿𝗴𝗲𝘁 𝗜𝗱𝗲𝗻𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 & 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 🗸 Track keynote – James Dale, Director of Drug Discovery, PharmEnable Therapeutics 🗸 Key speaker – Helen Bright PhD FRSM, CSO, Centauri Therapeutics Limited 🗸 Panel discussion - AI-Powered Technological Advancements For Novel Target Discovery 🔹𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗮𝗹 & 𝗖𝗼𝗺𝗽𝘂𝘁𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗵𝗲𝗺𝗶𝘀𝘁𝗿𝘆 🗸 Track keynote – Raul Villamarin Rodriguez, VP, Woxsen University 🗸 Key speaker – Andrew Woodhead, Head of Chemistry, Astex Pharmaceuticals 🔹𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗻𝗴 𝗧𝗮𝗿𝗴𝗲𝘁𝘀 𝗶𝗻𝘁𝗼 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 🗸 Track Keynote – Philippe Marc, Executive Director, Global Head of Integrated Data Sciences, Novartis 🗸 Key Speaker – Morten Grunnet, Prof, PhD, DrSci, VP & Head of Neuroscience, Lundbeck 🗸 Panel discussion - Translational Studies To Support Better Drug Design 🔹𝗙𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀 & 𝗖𝗲𝗹𝗹𝘂𝗹𝗮𝗿 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 🗸 Track Keynote – Davide Gianni, Senior Director, Discovery Sciences, GSK 🗸 Key Speaker – Roderick Beijersbergen, Head of NKI Genomics Core Facility, The Netherlands Cancer Institute 🔗 Secure your spot now: https://hubs.la/Q035yWhH0 #DrugDiscovery #AI #Biotech #Pharma

Congratulations to our colleague Emiliano Tamanini for winning third prize for his talk at the ‘Chemist in industry’ conference in Alderley Park on Wednesday, 19th February! Presentation title: ‘Discovery of ASTX295: A bone-marrow sparing MDM2 Antagonist. From concept to clinic’. https://lnkd.in/egiaaSfd

We are excited to announce that registration for the 2025 edition of the Fragment-Based Lead Discovery Conference is now open! Do you want to participate more actively? Then submit your abstract and get a chance to speak with Prof Anna K. H. Hirsch from Universität des Saarlandes and Prof Steve Fesik from Vanderbilt University: https://lnkd.in/guvzCjWj

🚀Discovery & Development Europe 2025 📅 23 - 24 June 2025, Basel, Switzerland Join 1,000 R&D leaders working in biology and chemistry in Basel at this renowned event. Gain insights to make informed pipeline decisions in early R&D, accelerating the journey from target identification to novel clinical candidates, ultimately increasing life-saving treatments for critical illnesses. Key Speakers Include: 🔹𝗧𝗮𝗿𝗴𝗲𝘁 𝗜𝗱𝗲𝗻𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 & 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 🗸 Track keynote – James Dale, Director of Drug Discovery, PharmEnable Therapeutics 🗸 Key speaker – Helen Bright PhD FRSM, CSO, Centauri Therapeutics Limited 🗸 Panel discussion - AI-Powered Technological Advancements For Novel Target Discovery 🔹𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗮𝗹 & 𝗖𝗼𝗺𝗽𝘂𝘁𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗵𝗲𝗺𝗶𝘀𝘁𝗿𝘆 🗸 Track keynote – Raul Villamarin Rodriguez, VP, Woxsen University 🗸 Key speaker – Andrew Woodhead, Head of Chemistry, Astex Pharmaceuticals 🔹𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗻𝗴 𝗧𝗮𝗿𝗴𝗲𝘁𝘀 𝗶𝗻𝘁𝗼 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 🗸 Track Keynote – Philippe Marc, Executive Director, Global Head of Integrated Data Sciences, Novartis 🗸 Key Speaker – Morten Grunnet, Prof, PhD, DrSci, VP & Head of Neuroscience, Lundbeck 🗸 Panel discussion - Translational Studies To Support Better Drug Design 🔹𝗙𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀 & 𝗖𝗲𝗹𝗹𝘂𝗹𝗮𝗿 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 🗸 Track Keynote – Davide Gianni, Senior Director, Discovery Sciences, GSK 🗸 Key Speaker – Roderick Beijersbergen, Head of NKI Genomics Core Facility, The Netherlands Cancer Institute 🔗 Secure your spot now: https://hubs.la/Q035yWhH0 #DrugDiscovery #AI #Biotech #Pharma

Congratulations to Jessie Stow for winning the Royal Society of Chemistry Apprentice Prize! 🏆

Have you checked out this week's Cambridge Independent yet? From the latest on the city's market, to reaction and analysis to the Chancellor's Oxford-Cambridge growth plans, we've packed a lot in. There's a fascinating in-depth interview with Zara Lachlan, the 21-year-old Cambridge woman who has just completed an incredible solo row from Europe to South America. And there are pictures of the stunning current light show Ely Cathedral. There's an update on the Beehive Centre redevelopment and a column by MP Pippa Heylings, plus pictures of nearly the whole team at The Cambridge Building Society as they its mark 175th anniversary. Columnist Paul Kirkley explains why, sadly, he's writing his final column for us. And in Culture, we feature The Levellers, Rob Auton, photography, wildlife and more. In Business, Princess Anne visits Thermoteknix, Lord Patrick Vallance visits Astex Pharmaceuticals and the shortlist for the ever-impressive #21toWatch Awards is revealed. Work on Cambridge Discovery Campus begins, there's an expert insight column from HCR Hewitsons and a solar scheme saves a salad packaging firm £30,000 a year. Plus, we have the latest on CN Bio , Ceres Agri-Tech Knowledge Exchange Partnership, Arecor Therapeutics and KPMG and Daniel Zeichner MP visits 9Barista. In Sport, we reflect on the incomings at Cambridge United Football Club and the form of Histon FC, plus much more. It's on sale all week, available for home delivery or use my name - PAULBRACKLEY - on our subscription page online for the best possible deal on annual digital subscription. You'll get our page-turning digital edition to read each week on your device or laptop, our full archive, access to our Premium website and our app, with more titles around the region and extra puzzles and content - all for £24.89 for a whole year. And you'll be supporting independent journalism at a time when it needs it most. Thank you to all those who have already subscribed - it's much appreciated. If you want a Business subscription package for up to five or 20 users, then use my code BIZPAUL for the best discount.